Mr. Hussain has been a director since February 2024. He has more than 30 years of global leadership and operating experience in the healthcare sector.
Mr. Hussain most recently served as the Chief Executive Officer of Vifor. He previously served as GlaxoSmithKline’s Global President, Pharmaceuticals & Vaccines. Earlier in his career, he served in various leadership roles at Eli Lilly and Company.
Mr. Hussain previously served on the boards of Teva Pharmaceuticals, Aspen Pharmacare, Vifor, ViiV Healthcare and Cochlear, among others.
Mr. Hussain holds a BSc from the Loughborough Institute of Technology and an MBA from the Fuqua School of Business at Duke University.